Skip to content

Enterprise value at other companies

Baxter International logo
Baxter InternationalBAX
$6.88B-55.6%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
ADMA Biologics logo
ADMA BiologicsADMA
$2.21B-52.5%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$13.12B+45.9%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$188.98M+39.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$297.01M-7.1%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s enterprise value?
Lifecore Biomedical, Inc. (LFCR) reported enterprise value of $324.44M in Q1 2026.
How has Lifecore Biomedical, Inc.'s enterprise value changed year-over-year?
Lifecore Biomedical, Inc.'s enterprise value increased by 23.8% year-over-year, from $262.04M to $324.44M.
What is the long-term trend for Lifecore Biomedical, Inc.'s enterprise value?
Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s enterprise value has grown at a -9.8% compound annual growth rate (CAGR), from $544.3M to $324.44M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.